Home / Insights / AQSCIR ?'G' in Pharmaceutical R&D

insights-espresso-icon whitepaper

AQSCIR ?'G' in Pharmaceutical R&D

Espresso-live Speakers
by Meenakshi L , Senior Research Analyst
27 June 2014

Procurement decisions are no longer limited to cost savings, quality and time; sustainability is the new addition to procurement decision making. Risks arising from environmental and social factors, compliance, value creation and external demand are driving sustainable procurement. Upcoming green cap regulations can put pressure on sourcing of all commodities and services including clinical trials. This makes it pertinent for R&D procurement groups to evaluate carbon intensity along clinical trial supply chain and adopt mitigation strategies

SHARE
Linkedin Twitter Facebook
Leave a comment

Please enter a valid name

Post your comment

Please select captcha

Instagram

Get more stories like this

Subscirbe for more news,updates and insights from Beroe

Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

Schedule a Demo Now